Cytokinetics (CYTK)
45.10 -0.90 (-1.96%) 09:55 ET [NASDAQ]
45.41 x 200 45.76 x 200
Realtime by (Cboe BZX)
45.41 x 200 45.76 x 200
Realtime 45.50 -0.50 (-1.09%) 06:50 ET
for Mon, Mar 3rd, 2025
Results
download Want to compare other data? Select Fields| Symbol | CYTK | ALKS | NUVL | ||
| Company | Cytokinetics | Alkermes Plc | Nuvalent Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 46.00 | 34.32 | 74.50 | ||
| High | 46.58 | 34.67 | 75.11 | ||
| Low | 45.04 | 34.32 | 74.50 | ||
| Last | 45.10 | 34.56 | 74.02 | ||
| Change | -0.90 | +0.23 | -0.96 | ||
| % Change | -1.96% | +0.67% | -1.28% | ||
| Volume | 45,660 | 43,378 | 3,445 | ||
| 20-Day Average Volume | 1,919,244 | 1,876,675 | 394,807 | ||
| Previous Close | 46.00 | 34.33 | 74.98 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.23 | 33.79 | 80.78 | ||
| 20-Day Raw Stochastic | 45.85% | 68.68% | 11.03% | ||
| 20-Day Relative Strength | 46.73% | 61.44% | 39.72% | ||
| Weighted Alpha | -31.08 | +29.33 | -16.15 | ||
| Today's Opinion | 96% Sell | 100% Buy | 88% Sell | ||
| Previous Opinion | 96% Sell | 100% Buy | 72% Sell | ||
| Last Month's Opinion | 64% Sell | 100% Buy | Hold | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.13% since 02/24/25 | -2.79% since 02/24/25 | -3.88% since 02/24/25 | ||
| Low | 42.87 on 02/28/25 | 33.73 on 02/28/25 | 72.95 on 02/28/25 | ||
| High | 48.67 on 02/25/25 | 35.69 on 02/25/25 | 78.10 on 02/25/25 | ||
| 1-Month | |||||
| %Chg | -5.77% since 02/03/25 | +12.26% since 02/03/25 | -11.61% since 02/03/25 | ||
| Low | 40.53 on 02/12/25 | 30.51 on 02/04/25 | 72.95 on 02/28/25 | ||
| High | 51.74 on 02/21/25 | 36.45 on 02/18/25 | 91.50 on 02/06/25 | ||
| 3-Month | |||||
| %Chg | -11.34% since 12/03/24 | +17.13% since 12/03/24 | -20.84% since 12/03/24 | ||
| Low | 40.53 on 02/12/25 | 27.70 on 01/13/25 | 69.58 on 01/13/25 | ||
| High | 52.80 on 01/27/25 | 36.45 on 02/18/25 | 97.02 on 12/04/24 | ||
| 6-Month | |||||
| %Chg | -16.29% since 09/03/24 | +22.80% since 09/03/24 | -10.33% since 09/03/24 | ||
| Low | 40.53 on 02/12/25 | 25.65 on 09/10/24 | 69.58 on 01/13/25 | ||
| High | 59.39 on 11/11/24 | 36.45 on 02/18/25 | 113.51 on 09/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,428,644 | 5,582,538 | 5,327,555 | ||
| Shares Outstanding, K | 118,014 | 162,614 | 71,053 | ||
| Annual Sales | 7,530,000 | 1,557,630,000 | 0 | ||
| Annual Net Income | -526,240,000 | 367,070,000 | -126,220,000 | ||
| Last Quarter Sales | 460,000 | 429,990,000 | 0 | ||
| Last Quarter Net Income | -160,550,000 | 146,500,000 | -84,350,000 | ||
| 60-Month Beta | 0.83 | 0.49 | 1.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 02/27/25 | 1.04 on 02/12/25 | -1.05 on 02/27/25 | ||
| Latest Earnings Date | 02/27/25 | 02/12/25 | 02/25/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.07 | 0.00 | ||